TARO-SODIUM FUSIDATE DIN 02565587
Status: Marketed
Holder: TARO PHARMACEUTICALS INC
Health Canada record
| Active ingredient(s) | FUSIDATE SODIUM 2 % |
|---|
| Dosage form | Ointment |
|---|
| Route | Topical |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | D06AX01 FUSIDIC ACID |
|---|
| Original market date | 11-Jun-2026 |
|---|
| Current status date | 11-Jun-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FUSIDATE SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|
| 00586676 | FUCIDIN OINTMENT 2% | LEO PHARMA INC | Ointment | FUSIDATE SODIUM 2 % | Marketed |
| 01934252 | FUCIDIN FILM COATED TAB 250MG | LEO PHARMA INC | Tablet | FUSIDATE SODIUM 250 MG | Cancelled Post Market |
| 00586684 | FUCIDIN INTERTULLE 2% | LEO PHARMA INC | Dressing | FUSIDATE SODIUM 2 % | Cancelled Post Market |
| 02049406 | FUCIDIN LEO INJECTION KIT | LEO PHARMA INC | Kit | FUSIDATE SODIUM 500 MG; SODIUM PHOSPHATE DIBASIC 10 ML | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 36845 | 2026-02-05 | Supplement to an Abbreviated New Drug Submission (SANDS) | Addition of new dosage form: Ointment |
Request a quote for TARO-SODIUM FUSIDATE
How to read a Canadian DIN record